Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.98M P/E - EPS this Y -78.00% Ern Qtrly Grth -
Income -25.9M Forward P/E -0.96 EPS next Y 61.20% 50D Avg Chg 12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -62.00%
Dividend N/A Price/Book 0.73 EPS next 5Y - 52W High Chg -99.00%
Recommedations 1.50 Quick Ratio 2.89 Shares Outstanding 8.49M 52W Low Chg 52.00%
Insider Own 66.23% ROA -57.24% Shares Float 2.06M Beta -0.29
Inst Own 12.25% ROE -117.36% Shares Shorted/Prior 33.26K/43.63K Price 0.55
Gross Margin - Profit Margin - Avg. Volume 380,464 Target Price 26.67
Oper. Margin - Earnings Date Nov 11 Volume 1,373,472 Change 9.69%
About NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and joint research agreement with Dong-A ST and ImmunoForge for the development of DA-1726. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

NeuroBo Pharmaceuticals, Inc. News
11/18/24 NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
11/15/24 Life Sciences Investor Forum: Presentations Now Available for Online Viewing
11/13/24 NeuroBo Pharmaceuticals to Participate in Investor Conferences in November
11/13/24 NRBO: Topline Results for Phase 2a Trial of DA-1241 in MASH Expected in December 2024...
11/12/24 Life Sciences Investor Forum Agenda Announced for November 14th
11/07/24 NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/04/24 NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
10/01/24 NRBO: Positive SAD Part 1 Data; MAD Part 2 Results Expected in 1Q25…
10/01/24 NeuroBo Pharmaceuticals to Participate in Investor Conferences in October
09/30/24 We're A Little Worried About NeuroBo Pharmaceuticals' (NASDAQ:NRBO) Cash Burn Rate
09/30/24 NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
09/03/24 NeuroBo to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08:34 AM NRBO: Data from Part 1 of Phase 1 Trial of DA-1726 in 3Q24…
08/14/24 NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update
08/14/24 NeuroBo concludes subject enrolment in SAD portion of obesity treatment trial
08/13/24 NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
08/06/24 NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together with Dong-A ST and ImmunoForge to Develop a Long-Acting Once-Monthly Formulation of DA-1726 for the Treatment of Obesity
07/30/24 NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01
07/17/24 Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
07/11/24 NeuroBo Pharmaceuticals to Present at the Emerging Growth Conference in July
NRBO Chatroom

User Image TraderRapp Posted - 10 minutes ago

$NRBO Waiting for December data release...

User Image Jw242 Posted - 1 day ago

$NRBO name change pump please?🙏

User Image Jw242 Posted - 2 days ago

$NRBO new ticker name is needed 🤪

User Image Pukkaa56 Posted - 3 days ago

$NRBO

User Image elitechrisvp Posted - 3 days ago

$NRBO 👀

User Image Akubra Posted - 5 days ago

$NRBO damn this stock is frustrating. I know the general market is down today but this just continues to lose

User Image ButterCapital Posted - 6 days ago

$NRBO adding back some

User Image TraderRapp Posted - 6 days ago

$NRBO just loaded some more...

User Image GemsOversold Posted - 1 week ago

$NRBO

User Image Jw242 Posted - 1 week ago

$NRBO someday 🤪

User Image TraderRapp Posted - 1 week ago

$NRBO so how is this any different from Altimune drug PemV?

User Image Beginner999 Posted - 1 week ago

$NRBO wants more

User Image BigTimePennyStocks Posted - 1 week ago

Small-Cap Watchlist for this Week: ( $NVNO, $DATS, $NRBO, $SKYQ, $LIPO ) Free Article with Catalysts in Bio #NASDAQ #NYSE

User Image gamgee11 Posted - 1 week ago

$EGIO $NRBO $NXPL $SUGP SUGP is gonna pay. Waiting on NXPL for awhile now

User Image TraderRapp Posted - 1 week ago

$NRBO no volume on their ER date? no love...

User Image Pukkaa56 Posted - 2 weeks ago

$NRBO

User Image Pukkaa56 Posted - 2 weeks ago

$NRBO

User Image elitechrisvp Posted - 2 weeks ago

$NRBO MASH

User Image Beginner999 Posted - 2 weeks ago

$NRBO very interesting

User Image TraderRapp Posted - 2 weeks ago

$NRBO this phase 2A news is only for their MASH drug not phase 1 obesity drug data...yet...FYI

User Image KingNeptune Posted - 2 weeks ago

$BOLD $TRVI $VTGN $NRBO are my $3 stocks I'm liking for positive movement through the end of the year. I'd add $SLS but it's not there yet. Very possible it'll be in the 3s by the EOY. What's everyone else thinking? About these or other $3 darlings?

User Image BioRich Posted - 2 weeks ago

@broadview19 @jonnyloitering I am, and good to know. Not sure what to make of $NRBO or price action since it was a bloodbath day. What's your take on $JL? Looks like they got crunched pretty hard.

User Image broadview19 Posted - 10/31/24

$NRBO Can someone please tell @Jw242 that I told him so? He blocked me. Please include me in on the post. Thanks!

User Image BioRich Posted - 10/30/24

@broadview19 @jonnyloitering Hey Bobby, thoughts on this? $NRBO looks like they just embarrased you (this is meant in friendly banter...we have no control with these, just hope from doing our DD). Cheers! If not $NRBO, what stocks would you suggest and feel confident about? Thanks in advance.

User Image BioRich Posted - 10/30/24

@broadview19 love that you watch this for us Bob so we don't have to. We know what we have in $NRBO and hope you see it soon too. Are you short on the stock or just like talking smack. Not hindered by either, just curious the infatuation. Cheers!

User Image BioRich Posted - 10/30/24

@jonnyloitering @broadview19 today showed us exactly what we can expect for the next few days/weeks. We're sitting on earnings seasons and a chaotic election. The world is still adapting to the impact of AI on jobs and we're seeing an influx of people into our country that's stressing our resources. Will definitely be interesting. Today was a trash day though. Many earnings beat and stocks got crushed. Lesson learned. No change in position on $NRBO and an optimistic future. Cheers!

User Image Jw242 Posted - 10/30/24

$NRBO oh well. Low volume destruction

User Image BioRich Posted - 10/29/24

@broadview19 @jonnyloitering Thanks broadview. I'm glad that you agree. No time table, but definitely believe this is a winner with $NRBO that we'll be happen with our return in. Cheers!

User Image BioRich Posted - 10/25/24

@jonnyloitering @broadview19 I agree completely Jonny. That would be my take too. I rode it out since I was focused on other winners and didn't want to play the "pick a price" game at the time. I think we're on to a winner though with $NRBO. Cheers!

User Image BioRich Posted - 10/25/24

@jonnyloitering @broadview19 Enjoy your vacation. Don't worry about the hate. I like $NRBO and believe in it. Might hit while you're not watching, might hit when you get back. Overall, I see this moving (with a jump as well). I think you're in good hands with this one. Let's make some money. Cheers!

Analyst Ratings
Maxim Group Buy May 8, 24